Skip to main content
Back
ICLR logo

ICON Public Limited Company

Data quality: 100%
ICLR
NASDAQ Healthcare Medical - Diagnostics & Research
$100.35
▲ $0.65 (0.65%)
Mkt Cap: 7.66B
Day Range
$99.88 $103.35
52-Week Range
$66.57 $211.00
Volume
802,780
50D / 200D Avg
$136.39 / $161.56
Prev Close
$99.70

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 9.7 0.4
P/B 0.8 2.9
ROE % 8.4 3.7
Net Margin % 9.6 3.8
Rev Growth 5Y % 31.2 10.0
D/E 0.4 0.2

Key Takeaways

Revenue grew 31.17% annually over 5 years — strong growth
Earnings grew 29.26% over the past year
Debt/Equity of 0.38 — conservative balance sheet
Generating 1.12B in free cash flow
P/E of 9.68 — trading at a low valuation
PEG of 0.76 suggests growth is underpriced

Growth

Revenue Growth (5Y)
31.17%
Revenue (1Y)1.99%
Earnings (1Y)29.26%
FCF Growth (3Y)62.97%

Quality

Return on Equity
8.44%
ROIC6.27%
Net Margin9.56%
Op. Margin13.26%

Safety

Debt / Equity
0.38
Current Ratio1.26
Interest Coverage4.63

Valuation

P/E Ratio
9.68
P/B Ratio0.80
EV/EBITDA9.77
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.99% Revenue Growth (3Y) 3.43%
Earnings Growth (1Y) 29.26% Earnings Growth (3Y) 25.15%
Revenue Growth (5Y) 31.17% Earnings Growth (5Y) 24.65%
Profitability
Revenue (TTM) 8.28B Net Income (TTM) 791.47M
ROE 8.44% ROA 4.69%
Gross Margin 29.42% Operating Margin 13.26%
Net Margin 9.56% Free Cash Flow (TTM) 1.12B
ROIC 6.27% FCF Growth (3Y) 62.97%
Safety
Debt / Equity 0.38 Current Ratio 1.26
Interest Coverage 4.63 Dividend Yield 0.00%
Valuation
P/E Ratio 9.68 P/B Ratio 0.80
P/S Ratio 0.93 PEG Ratio 0.76
EV/EBITDA 9.77 Dividend Yield 0.00%
Market Cap 7.66B Enterprise Value 10.73B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 8.28B 8.12B 7.74B 5.48B 2.80B
Net Income 791.47M 612.34M 505.30M 153.19M 327.81M
EPS (Diluted) 9.53 7.40 6.13 2.25 6.24
Gross Profit 2.44B 2.40B 2.21B 1.51B 808.03M
Operating Income 1.10B 956.15M 795.24M 378.53M 391.50M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 16.88B 16.99B 17.19B 17.39B 3.44B
Total Liabilities 7.35B 7.75B 8.69B 9.32B 1.59B
Shareholders' Equity 9.52B 9.24B 8.50B 8.07B 1.85B
Total Debt 3.60B 3.94B 4.83B 5.65B 433.61M
Cash & Equivalents 538.79M 378.10M 288.77M 752.21M 840.31M
Current Assets 3.53B 3.41B 3.23B 2.94B 2.10B
Current Liabilities 2.80B 2.83B 2.69B 2.48B 1.12B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#491 of 820
37
Value Defensive Investing (Benjamin Graham)
#310 of 708
32

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026